Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
Best Of BRK.ABest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd
Search
Shrewd'm.com Merry shrewd investors
Search
Best Of BRK.ABest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd


The week's question
In December 2024, in the thread "Re: BRK: Why Not XOM?", BreckHutHigh asked the members: "What about the long road trips with kids?" This week it is put to everyone again. The button below opens the small thread re-asking it - read what others have said so far, then give your own answer as an ordinary reply.
Answer this questionContinue to Shrewd'mThis note won't appear again
Stocks A to Z / Stocks B / Berkshire Hathaway (BRK.A)
Unthreaded | Threaded | Whole Thread (14) |
Author: YoungandOld   😊 😞
Number: of 21943 
Subject: Re: OT: gain of function research
Date: 06/20/23 12:30 PM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 9
Why would scientists be genuinely interested in gain of function research?

There is a big strategic priority in the US and other countries around preparedness for biothreats. Particularly from parties that are not a part of any well regulated entity or groups that follow / adhere to international agreements. Biothreats often include taking clinical pathogens and modifying them to enhance a biological feature (e.g., resistance to certain treatments/drugs, ability to increase spread capability, increase virulence).

If you were charged with being the front line defense mechanism to deal with biothreats, you might want your scientists figuring how mechanisms that could weaponize something that has already shown virulence (e.g., Ebola) might be countered? Is there a vaccine that would work, are there counterpathogens that could counteract the virulent strains, etc? Its difficult to have preparedness and to have fast response capability if your scientists haven't studied those mechanisms. Because its very hard to figure it out just by capturing those biothreats after the fact. So you have to have a sense of what things are possible, which things are harder and easier to execute, and how long lasting and impactful particular designs might be.

Its dangerous because of course these things can become weapons and dangerous. But if you consider yourself the "good guy", which of course everyone does in their own mind, it seems irresponsible not to work on them in well controlled contexts (e.g., BSL Level 4 labs).
Post New | Post Reply | Report Post | Recommend It!
Print the post
Members reply directly to YoungandOld here — and replies get answered. Reading is free; so is joining the conversation. Join Shrewd'm »
This community has written 21,448 posts about Berkshire Hathaway. The article-length ones it recommended most:
BRK: Why Not XOM? · 62 recs · 2024
Second quarter comments · 60 recs · 2023
Berkshire's Profit Contributors · 57 recs · 2023
Summary of 2Q 2026 · 54 recs · 2026
3Q Summary · 53 recs · 2024
Unthreaded | Threaded | Whole Thread (14) |


Announcements
Berkshire Hathaway FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Best Of BRK.A | Best Of | Favourites & Replies | All Boards | Followed Shrewds | Open Questions | Moving a community